2月26日下午，山东省人民政府政策例行吹风会举行，解读省委、省人民政府近日印发的《关于实施更 加积极开放有效人才政策的若干措施》（以下简称《若干措施》）。 《若干措施》在"育"上下真功，让本土人才长得快、挑大梁。解决人才短板，根本在于强化自主培养能 力，不仅要从外面请人才，更要让本土人才快速成长起来。实施领军人才"筑峰行动"，整合项目、平台 等科研资源，对"筑峰计划"人选实行"一人一策"精准支持，同时对新当选和仍在科研一线的两院院士团 队给予稳定项目支持，让他们沉下心来搞研究、十年磨一剑。构建青年人才"梯队工程"，进一步推动省 级重点人才工程向标志性产业链聚焦，优先支持以"领军人才+青年人才"模式组团申报，让更多青年骨 干在承担重大任务中经风雨、长本领。持续实施省海外优青项目，聚力打造全省优秀青年科学家培育 库，让青年人才在山东能够坐得住"冷板凳"、出得了"大成果"。优化创业人才"孵化体系"，加快推进国 家大学科技园优化重塑，鼓励有条件的园区打造"零租"孵化器——不收租金、直接入驻。布局一批省级 引领型孵化器等双创载体，支持国内高水平大赛获奖项目来鲁落地，为更多人才提供低成本、全要素的 创业"微生态"。 《若 ...

从市州分布来看，长沙市入库企业数量遥遥领先，达256家；其次是株洲市86家、郴州市72家；衡阳市、邵阳市、娄底 市、岳阳市、益阳市、永州市、湘潭市上市后备企业数量均达40家及以上。 来源：张家界事儿 近日，省委金融办对2025年湖南省上市后备企业资源库入库企业名单（以下简称：名单）进行公示，共有891家企业入 库。 从行业分布来看，湖南省上市后备企业覆盖各个行业，新一代信息技术、高端装备、新材料、生物医药等战略新兴领 域占比颇高。其中，制造业入库企业最多，达180家，占比约20.20%，其次是新材料，入库企业122家，占比约 13.69%。 本次入库企业的科技与创新浓度高，科创板后备企业有257家，占比近3成。 记者还关注到，不少入库企业已与资本市场越来越近。如名单公布当天，北交所上市委员会2025年第46次审议会议落 下帷幕，英氏控股集团股份有限公司成功过会。 附：2025年湖南省上市后备企业资源库入库企业名单 | | | 2025年湖南省上市后备企业资源库入库企业名单 | | | | --- | --- | --- | --- | --- | | 序号 | 企业名称 | 所属市州 | 证监会行业 | 料创 ...

12月22日，省委金融办对2025年湖南省上市后备企业资源库入库企业名单进行公示，共有891家企业入库。 从市州分布来看，长沙市入库企业数量遥遥领先，达256家；其次是株洲市86家、郴州市72家；衡阳市、邵阳市、娄底 市、岳阳市、 益阳市、永州市、湘潭市上市后备企业数量均 达40家及以上。 | | 湖南省上市后备企业市州分布(单位:家) | | | | --- | --- | --- | --- | | 市州 | 2025年 | 2024年 | 2023年 | | 长沙市 | 256 | 241 | 259 | | 株洲市 | 86 | 83 | 88 | | 柄 市 | 72 | 71 | 64 | | 衡阳市 | 66 | 58 | 58 | | 娄底市 | 63 | 62 | 64 | | 邵阳市 | 62 | 62 | 57 | | 岳阳市 | 57 | 60 | 69 | | 益阳市 | 48 | 41 | 43 | | 水州市 | 45 | 49 | 44 | | 湘潭市 | 44 | 40 | 43 | | 常德市 | 33 | 37 | 55 | | 怀化市 | 23 | 41 | 38 | ...

Core Viewpoint - The Hunan Provincial Financial Office has announced the list of 891 companies included in the 2025 reserve for potential public listings, indicating a growing interest in capital markets and innovation in the region [1][4]. Group 1: Company Distribution - The distribution of listed reserve companies across cities shows that Changsha leads with 256 companies, followed by Zhuzhou with 86 and Chenzhou with 72 [2]. - Other cities with significant numbers include Hengyang (66), Shaoyang (62), Loudi (63), and Yiyang (48), all having over 40 companies [2]. Group 2: Industry Distribution - The reserve companies span various industries, with a notable concentration in strategic emerging sectors such as new generation information technology, high-end equipment, new materials, and biomedicine [3]. - Manufacturing has the highest representation with 180 companies, accounting for approximately 20.20% of the total, followed by new materials with 122 companies, making up about 13.69% [3]. Group 3: Innovation and Market Proximity - The list includes a high concentration of technology and innovation-focused companies, with 257 firms (nearly 30%) being potential candidates for the Sci-Tech Innovation Board [4]. - Many of the listed companies are increasingly approaching capital markets, as evidenced by the successful review of Ying's Holdings Group Co., Ltd. by the Beijing Stock Exchange on the same day the list was published [4].

Group 1: Event Overview - The 2025 Sustainable Global Leaders Conference will be held from October 16 to 18 in Shanghai at the Expo Park [1] - The conference is co-hosted by the World Green Design Organization (WGDO) and Sina Group, with support from the Shanghai Huangpu District Government [1] Group 2: Key Themes and Discussions - The conference will focus on topics such as "Creating a Sustainable Development Model in the East" and "Decoding the Sustainable Drivers of Shanghai's Industrial Upgrade" [1] - The Shenergy Group will participate as a global partner and lead discussions on "Shanghai's Actions and Multi-dimensional Collaboration in Global Transformation" [1] Group 3: Company Insights - China Pacific Insurance's Vice President and Chief Investment Officer, Su Gang, emphasized that technological innovation is the primary driver of development [3] - Su Gang highlighted that insurance plays a crucial role in mitigating uncertainties faced by tech companies during their initial stages [3] - In 2024, China Pacific Insurance served over 10,000 tech enterprises, focusing on three emerging industries and providing over 1 billion RMB in guarantees for clinical trials and drug safety for 191 innovative pharmaceutical companies [3] Group 4: Investment Strategies - China Pacific Insurance aims to leverage its insurance funds as "patient capital" and "long-term capital" to support technological innovation [3] - The company has established private equity funds and invested in state-owned parent funds and leading industry funds, focusing on strategic emerging sectors such as healthcare, advanced manufacturing, artificial intelligence, and digital technology [3] - As of the end of last year, the cumulative investment scale of China Pacific Insurance in the technology sector exceeded 100 billion RMB [3]

Core Insights - The company provided a detailed explanation regarding financial accounting issues in response to an inquiry about its stock issuance to specific targets, covering accounts receivable, contract assets, fixed assets, goodwill, and fundraising project details [1] Financial Condition Analysis - Accounts Receivable and Contract Assets: The book value of accounts receivable at the end of the reporting periods was 1,201.76 million, 1,274.05 million, 1,327.78 million, and 1,375.03 million, accounting for 41.08%, 38.59%, 40.67%, and 45.32% of current assets respectively. The accounts receivable turnover rates were 2.40, 2.33, 2.47, and 0.46. The book value of contract assets was 148.38 million, 181.66 million, 361.85 million, and 401.43 million, representing 5.07%, 5.50%, 11.08%, and 13.23% of current assets respectively. The high proportion of accounts receivable and contract assets to revenue is due to lengthy payment approval processes in specific downstream industries, but there are no significant risks of bad debts [2] - Fixed Assets: The book value of fixed assets at the end of the reporting periods was 1,401.31 million, 1,354.61 million, 2,209.42 million, and 2,159.47 million, making up 53.31%, 48.91%, 67.16%, and 64.44% of non-current assets respectively. The increase in fixed assets by the end of 2024 is attributed to the capitalization of construction in progress amounting to 821.71 million. The company has adequately provided for fixed asset impairment, and the accounting treatment complies with the Accounting Standards for Enterprises [2] - Goodwill: The book value of goodwill at the end of the reporting periods was 249.80 million, 199.13 million, 166.53 million, and 168.80 million, accounting for 9.50%, 7.19%, 5.06%, and 5.04% of non-current assets respectively. The company has made significant impairment provisions for goodwill, and the testing process for goodwill impairment is cautious and reasonable [2] Fundraising Project Details - The company plans to raise no more than 1,300.00 million through a specific stock issuance, with net proceeds primarily allocated to projects in aviation equipment testing, AI chip testing, satellite internet quality assurance, data intelligence quality inspection, and upgrading the Xi'an metrology laboratory, along with supplementing working capital [3] - Project Necessity and Reasonableness: The fundraising projects focus on strategic emerging fields such as aviation equipment, AI, satellite internet, and digital economy, enhancing the company's capabilities and service quality. The company has the necessary personnel and technology reserves, and there are no significant uncertainties regarding project implementation [3] - Investment Composition and Progress: The investment structure of the fundraising projects is reasonable, with necessary expenditures. The construction period for these projects is expected to be from 2026 to 2028, and as of the report date, no construction has commenced [3] - Benefit Assessment: The benefit assessment of the fundraising projects considers performance fluctuations, with expected internal rates of return and payback periods indicating good economic benefits. The average gross profit margins of the new projects are mostly lower than existing levels, and the net profit compound annual growth rate is similar or slightly lower than current business [3]

Core Insights - Jiangsu Province has recognized 156 private technology enterprises in Suzhou's Xiangcheng District from 2022 to 2024, highlighting the region's technological strength and innovation capabilities [1][3]. Group 1: Private Technology Enterprises - Private technology enterprises are defined as non-state-owned resident enterprises registered in Jiangsu Province that engage in research and development, technology transfer, and possess core independent intellectual property rights [1]. - The recognized enterprises span various strategic emerging sectors, including industrial design, advanced materials, and precision machinery, showcasing the diverse technological landscape of Huangqiao Street [3]. Group 2: Company Profiles - Suzhou Xuanang Industrial Design Co., Ltd. specializes in comprehensive design services, including trend research, product design, and mass production engineering, having participated in over 2000 product designs across multiple industries [2]. - Suzhou Miaohai Nanotechnology Co., Ltd., established in 2022, focuses on the R&D, production, and sales of lithium battery MXene/CNTs composite additives, providing a full range of services from raw material processing to performance testing [3]. Group 3: Future Directions - Huangqiao Street aims to enhance the quantity, quality, and structural optimization of private technology enterprises, fostering distinctive industrial clusters and contributing to the high-quality development of the private economy [5].

Group 1 - The latest stock price of China Haicheng is 10.76 yuan, up 0.28% from the previous trading day, with a trading volume of 0.74 billion yuan [1] - The company's main business is engineering consulting services, including general contracting, engineering design, and engineering supervision, with a registered location in Shanghai [1] - In the first half of 2025, the company's general contracting business achieved revenue of 2.143 billion yuan, accounting for 78.07% of total revenue [1] Group 2 - The latest semi-annual report for 2025 shows that the company achieved operating revenue of 2.745 billion yuan, a year-on-year increase of 0.67%, and a net profit attributable to shareholders of 152 million yuan, a year-on-year increase of 8.52% [1] - The basic earnings per share for the reporting period is 0.33 yuan [1] - The company is actively expanding into strategic emerging fields such as the biotechnology industry, new energy, and new materials [1] Group 3 - On August 26, the net outflow of main funds was 8.9102 million yuan, with a cumulative net outflow of 34.9148 million yuan over the past five trading days [2]

Core Viewpoint - The company reported strong financial performance for the first half of 2025, with significant growth in revenue and net profit, driven by stable orders and new product sales [1][2]. Financial Performance - The company achieved operating revenue of 461 million yuan, representing a year-on-year increase of 16.46% [1]. - Net profit reached 127 million yuan, marking a year-on-year growth of 31.52% [1]. - Basic earnings per share were reported at 0.72 yuan [1]. Business Development - The company experienced stable growth in orders for mobile source denitrification molecular sieves sold to BASF, contributing to revenue growth [1]. - Sales of titanium-silicon series epoxy propylene catalysts saw a breakthrough, with new customer development enhancing order quantities [1]. - The sales volume of pyridine catalysts also increased compared to the previous year, providing new growth points for revenue and profit [1]. Strategic Initiatives - The company aims to deepen strategic collaboration with global customers and partners through technological innovation and resource integration [1]. - There is a focus on expanding market share and enhancing brand value and competitive advantage [1]. - The company is committed to developing high-purity silicon-aluminum materials for strategic emerging fields such as semiconductors and photovoltaics, aiming to create a technology barrier and product matrix driven by market demand [1]. Product Applications - The company's epoxy propylene catalysts are used in downstream products like polyurethane and propylene glycol, applicable in furniture, home appliances, automotive, and coatings [2]. - The HPPO process catalyst developed using titanium-silicon molecular sieve technology is characterized by high selectivity, high activity, good stability, and long service life [2]. - The company is one of the few in China capable of providing a complete process solution for the HPPO method of epoxy propylene, offering comprehensive technical services from process technology to final products [2]. Future Plans - The company will make prudent decisions regarding capital operations based on its development strategy and market conditions, actively exploring high-quality enterprises with strong upstream and downstream relevance [2]. - Capital operations will be pursued at the appropriate time, adhering strictly to relevant laws and regulations for information disclosure [2].

Group 1 - The core point of the news is that Qiaoyuan Co., Ltd. plans to invest in a special gas production base for electronic and medical-grade gases, aiming to enter strategic emerging fields such as semiconductor manufacturing and new displays [1][3] - The total planned investment for the project is 302 million yuan, with the first phase involving an investment of approximately 152 million yuan to establish a production capacity of 20,000 tons/year for electronic-grade carbon dioxide and medical-grade carbon dioxide, among others [1][3] - The second phase of the project will involve an additional investment of about 150 million yuan, focusing on the construction of production lines for electronic-grade medical carbon dioxide and ultra-pure ammonia [1][3] Group 2 - Qiaoyuan Co., Ltd. is a comprehensive gas supplier specializing in the research, production, sales, and service of high-purity gases, with a product range that includes high-purity oxygen, nitrogen, and argon [2] - The company has established a robust gas supply and service network, particularly in the southwestern region of China, where it operates the largest full-liquid air separation gas production line [2] - The industrial gas sector is supported by national policies, with multiple government departments promoting the development of the industrial gas industry, which is crucial for various emerging and foundational industries [3] Group 3 - The investment is expected to significantly enhance the supply capacity of sterile gases, meeting the increasing demand for medical gases in biopharmaceuticals and high-end medical devices [3] - Qiaoyuan Co., Ltd. anticipates that this investment will allow it to break through electronic specialty gas technology processes and expand into the semiconductor supply chain, thereby diversifying its product matrix [3] - The company has projected a net profit of 100 million to 120 million yuan for the first half of 2025, representing a year-on-year growth of 34.38% to 61.26% due to increased production capacity and sales [4]